TickerFacts.

Microbot Medical Inc. (MBOT): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2012-12-31, 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$6.28M
Year ended 2025-12-31
$5.87M
Trailing 12 months to 2026-06-30
-6.7%
3-year compound annual growth
+13.1%
5-year compound annual growth
$21.50M2009-12-31: $19.93M2010-12-31: $21.02M2011-12-31: $19.94M2012-12-31: $14.68M2013-12-31: $19.37M2014-11-30: $21.50M2015-12-31: -$823.0K2016-12-31: -$901.0K2017-12-31: $1.10M2018-12-31: $2.52M2019-12-31: $3.05M2020-12-31: $3.40M2021-12-31: $6.15M2022-12-31: $7.74M2023-12-31: $5.72M2024-12-31: $6.63M2025-12-31: $6.28M$6.28M
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$6.28M-5.2%2026-03-26, From 2025-01-01
2024-12-31$6.63M+15.8%2026-03-26, From 2024-01-01
2023-12-31$5.72M-26.0%2025-03-25, From 2023-01-01
2022-12-31$7.74M+25.7%2024-03-27, From 2022-01-01
2021-12-31$6.15M+81.2%2023-03-31, From 2021-01-01
2020-12-31$3.40M+11.4%2022-03-31, From 2020-01-01
2019-12-31$3.05M+21.2%2021-03-31, From 2019-01-01
2018-12-31$2.52M+128.6%2020-04-14, From 2018-01-01
2017-12-31$1.10Mn/c2019-04-01, From 2017-01-01
2016-12-31-$901.0Kn/m2018-04-02, From 2016-01-01
2015-12-31-$823.0Kn/a2017-03-21, From 2015-01-01
2014-11-30$21.50Mn/a2016-03-15, From 2013-12-01
2013-12-31$19.37M+31.9%2016-03-15, From 2013-01-01
2012-12-31$14.68Mn/c2015-03-13, From 2012-01-01
2011-12-31$19.94M-5.1%2014-03-13, From 2011-01-01
2010-12-31$21.02M+5.5%2013-03-21, From 2010-01-01
2009-12-31$19.93Mn/a2012-03-15, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Microbot Medical Inc. (MBOT)2025-12-31$6.28M-5.2%
TELA Bio, Inc. (TELA)2025-12-31$9.22M+4.6%
Profound Medical Corp. (PROF)2025-12-31$20.60M+21.4%
PRO DEX Inc (PDEX)2026-06-30$3.35M-8.0%
SS Innovations International, Inc. (SSII)2025-12-31$3.69M+47.9%
LENSAR, Inc. (LNSR)2025-12-31$5.62M+5.5%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$2.10M-11.9%
Pulse Biosciences, Inc. (PLSE)2025-12-31$44.72M+38.3%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$20.13M+226.0%

Compare MBOT, TELA, PROF, PDEX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗